Call Us08045477330
Imatinib Tablet IP 400 mg

Imatinib Tablet IP 400 mg

Product Details:

  • Salt Composition Imatinib Mesylate
  • Dosage Form Tablet
  • Indication Used in the treatment of Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST), and other cancers
  • Feature Each tablet contains 400 mg Imatinib Mesylate; high bioavailability
  • Ingredients Imatinib Mesylate, excipients
  • Application Oral anti-cancer medication
  • Physical Color/Texture Light yellow, film-coated tablet
  • Click to View more
X

Imatinib Tablet IP 400 mg Price And Quantity

  • 1 Unit
  • 450 INR

Imatinib Tablet IP 400 mg Product Specifications

  • Each tablet contains 400 mg Imatinib Mesylate; high bioavailability
  • Used in the treatment of Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST), and other cancers
  • Store below 30C, protect from moisture and direct sunlight
  • Light yellow, film-coated tablet
  • 24-36 months
  • Imatinib Mesylate, excipients
  • Imatinib Mesylate
  • Oral anti-cancer medication
  • Odorless
  • Tablet

Imatinib Tablet IP 400 mg Trade Information

  • 1* 10 Tablets
  • All India
  • GMP

Product Description



Buy the wondrous IMATINIB Tablet IP 400 mg and jump on this potent therapeutic option for chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), and select other cancers. IMATINIB Tablet IP is a polished, FDA-compliant, and prescription-only oral anticancer tablet with reduced side effects. Each oval, light yellow, film-coated tablet contains 400 mg of high-bioavailability Imatinib Mesylate and is identified by strength or brand. Packaged in durable blister strips with a labeled carton, this product ensures reliable storage and handling for up to 2436 months. Available for distributor, exporter, supplier, trader, and wholesaler use across India.

Advanced Application and Benefits of IMATINIB Tablet IP 400 mg

IMATINIB Tablet IP 400 mg is administered orally, ensuring patient convenience and adherence. Its primary application is in treating CML and GIST, but its potent action also extends to certain other cancer types. Key competitive advantages include superior bioavailability, strict compliance with Indian Pharmacopoeia standards, and a reduced incidence of adverse reactions. This tablets reliable formulation guarantees consistent efficacy, making it the go-to choice for healthcare practitioners and patients seeking a polished, high-performing anti-cancer medication.


Sample Policy, Packaging, and Export Market Details

We supply IMATINIB Tablet IP 400 mg with careful expenditure tracking, offering affordable sample policies for businesses wishing to trial our product. Each batch is handed over in secure blister strips within a labeled carton, protecting the tablets from moisture and sunlight. We prioritize steadfast packaging to maintain quality during long-distance shipping. Our main export markets span India and international regions, enabling global distributors and wholesalers to access this vital anticancer solution promptly and reliably.


FAQs of Imatinib Tablet IP 400 mg:


Q: How should IMATINIB Tablet IP 400 mg be administered?

A: IMATINIB Tablet IP 400 mg should be taken orally with a glass of water, as prescribed by your healthcare provider. It is important to follow the recommended dosage and timing instructions for optimal efficacy.

Q: What conditions does IMATINIB Tablet IP 400 mg primarily treat?

A: This medication is primarily used for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It may also be utilized for other cancers as determined by your physician.

Q: When should the IMATINIB Tablet IP 400 mg not be used?

A: IMATINIB Tablet IP 400 mg should not be used by individuals who have known hypersensitivity to imatinib or any of its excipients. Always consult your healthcare provider for a thorough evaluation of potential contraindications.

Q: Where is IMATINIB Tablet IP 400 mg manufactured and supplied?

A: IMATINIB Tablet IP 400 mg is manufactured and supplied in India and is available for distribution to both domestic and international markets.

Q: What are the main advantages of choosing IMATINIB Tablet IP 400 mg?

A: Key advantages include high bioavailability, polished manufacturing processes adhering to IP standards, reduced side effect risks, and practical packaging that ensures stability and longevity up to 2436 months.

Q: How is the product packaged for export and distributed to wholesalers?

A: Each batch is securely packaged in blister strips and labeled cartons to protect the tablets from moisture and sunlight, ensuring that product integrity is maintained throughout storage and transit.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Tablets' category